UBS Group
OCEA

UBS Group’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

UBS Group’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-246,259
Closed -$13.3K – 11163
2025
Q1 		$13.3K Buy
246,259
+191,112
+347% +$45.7K ﹤0.01% 8467
2024
Q4 		$30.5K Buy
55,147
+54,995
+36,181% +$43.3K ﹤0.01% 7591
2024
Q3 		$149 Sell
152
-2,483
-94% -$2.66K ﹤0.01% 9111
2024
Q2 		$3.21K Sell
2,635
-9,298
-78% -$15.9K ﹤0.01% 8244
2024
Q1 		$45.2K Sell
11,933
-4,563
-28% -$8.58K ﹤0.01% 6555
2023
Q4 		$10.9K Buy
16,496
+11,636
+239% +$16K ﹤0.01% 7416
2023
Q3 		$19K Sell
4,860
-1,490
-23% -$6.85K ﹤0.01% 6834
2023
Q2 		$38.2K Buy
6,350
+340
+6% +$1.99K ﹤0.01% 6610
2023
Q1 		$39.9K Buy
+6,010
New +$50.8K ﹤0.01% 6604

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

UBS Group's OCEA Position: Q2 2025 in Review

UBS Group sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 246,259 shares — an estimated $13.3K sold.

UBS Group first reported a position in OCEA in Q1 2023 and held it in 9 quarters. The position peaked at $45.2K in Q1 2024. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • UBS Group reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 246,259 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $13.3K.
  • UBS Group first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2023 and held it in 9 quarters.
  • UBS Group's Ocean Biomedical, Inc. Common Stock position peaked at $45.2K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.